Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.
about
Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737.
P2860
Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@ast
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@en
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@nl
type
label
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@ast
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@en
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@nl
prefLabel
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@ast
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@en
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@nl
P2860
P1433
P1476
Susceptibility of myelomonocyt ...... is cell cycle phase-dependent.
@en
P2093
David Kessel
John J Reiners
P2860
P304
P356
10.1016/J.CANLET.2004.09.012
P407
P577
2005-04-01T00:00:00Z